NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring
NeoGenomics Reports Second Quarter 2026 Results
Quarterly report [Sections 13 or 15(d)]
Current report
Definitive proxy statements
View and filter by group or type
